{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:46:44Z","timestamp":1787741204988,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["1024011000011-7-1.4.2"],"award-info":[{"award-number":["1024011000011-7-1.4.2"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["FEEM-2024-0011"],"award-info":[{"award-number":["FEEM-2024-0011"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.nano.2025.102811","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:24:51Z","timestamp":1740745491000},"page":"102811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Ultrasmall maghemite nanoparticles as MRI contrast agent: Unique combination of aggregation stability, low toxicity, and tumor visualization"],"prefix":"10.1016","volume":"65","author":[{"given":"Ekaterina O.","family":"Moiseeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod A.","family":"Skribitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia A.","family":"Finogenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei V.","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E.","family":"Shpakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor S.","family":"Sergeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria A.","family":"Terentyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Sindeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg A.","family":"Kulikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Lipengolts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Yu.","family":"Grigorieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102811_bb0005","author":"Vlaardingerbroek"},{"key":"10.1016\/j.nano.2025.102811_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ird3.100","article-title":"Deep learning-based reconstruction on intensity-inhomogeneous diffusion magnetic resonance imaging","volume":"2","author":"Zhu","year":"2024","journal-title":"iRADIOLOGY"},{"key":"10.1016\/j.nano.2025.102811_bb0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ird3.105","article-title":"Artificial intelligence in the diagnosis of cerebrovascular diseases using magnetic resonance imaging: A scoping review","volume":"2","author":"Wang","year":"2024","journal-title":"iRADIOLOGY"},{"key":"10.1016\/j.nano.2025.102811_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ird3.34","article-title":"Application and progress of X-ray, computed tomography, and magnetic resonance imaging radiomics in osteosarcoma","volume":"1","author":"Peihong","year":"2023","journal-title":"iRADIOLOGY"},{"key":"10.1016\/j.nano.2025.102811_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jmri.25625","article-title":"Gadolinium-based contrast agents: a comprehensive risk assessment","volume":"46","author":"Fraum","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nano.2025.102811_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpneph0660","article-title":"What nephrologists need to know about gadolinium","volume":"3","author":"Penfield","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.nano.2025.102811_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11547-017-0757-3","article-title":"Gadolinium retention in the body: what we know and what we can do","volume":"122","author":"Tedeschi","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.nano.2025.102811_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-8993(91)91527-8","article-title":"Gadolinium block of calcium channels: influence of bicarbonate","volume":"563","author":"Boland","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.nano.2025.102811_bb0045","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/ijms25074071","article-title":"Toxicity mechanisms of gadolinium and gadolinium-based contrast agents\u2014a review","volume":"25","author":"Coimbra","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102811_bb0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI contrast agents: current challenges and new frontiers","volume":"119","author":"Wahsner","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2025.102811_bb0055","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1148\/radiol.2017162759","article-title":"Ten things you might not know about iron oxide nanoparticles","volume":"284","author":"Daldrup-Link","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2025.102811_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jmri.24330","article-title":"Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases","volume":"40","author":"Bashir","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nano.2025.102811_bb0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/inorganics8040028","article-title":"Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging","volume":"8","author":"Fern\u00e1ndez-Barahona","year":"2020","journal-title":"Inorganics"},{"key":"10.1016\/j.nano.2025.102811_bb0070","series-title":"Safety and biological effects in MRI","author":"Shrivastava","year":"2020"},{"key":"10.1016\/j.nano.2025.102811_bb0075","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1021\/acsanm.3c04269","article-title":"Radiolabeled iron oxide nanomaterials for multimodal nuclear imaging and positive contrast magnetic resonance imaging (MRI): a review","volume":"6","author":"Pellico","year":"2023","journal-title":"ACS Applied Nano Materials"},{"key":"10.1016\/j.nano.2025.102811_bb0080","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nano.2018.01.014","article-title":"Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: therapeutic benefits, toxicity, mechanistic insights, and translational considerations","volume":"14","author":"Shah","year":"2018","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.nano.2025.102811_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.kint.2016.12.037","article-title":"Current and potential imaging applications of ferumoxytol for magnetic resonance imaging","volume":"92","author":"Toth","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nano.2025.102811_bb0090","series-title":"Molecular and cellular MR imaging","author":"Modo","year":"2007"},{"key":"10.1016\/j.nano.2025.102811_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1064-9689(21)00553-5","article-title":"Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review","volume":"4","author":"Petersein","year":"1996","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.nano.2025.102811_bb0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.crad.2016.03.020","article-title":"Cardiovascular MRI with ferumoxytol","volume":"71","author":"Finn","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.nano.2025.102811_bb0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.0b013e31829bfd8f","article-title":"Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL","volume":"81","author":"Farrell","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nano.2025.102811_bb0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1148\/radiol.2015150952","article-title":"Noninvasive differentiation between hepatic steatosis and steatohepatitis with MR imaging enhanced with USPIOs in patients with nonalcoholic fatty liver disease: a proof-of-concept study","volume":"278","author":"Smits","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2025.102811_bb0115","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1073\/pnas.1424993112","article-title":"Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients","volume":"112","author":"Gaglia","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2025.102811_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2252011605","article-title":"Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement","volume":"225","author":"Michel","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2025.102811_bb0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00467-014-2953-x","article-title":"High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort","volume":"30","author":"Nayak","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nano.2025.102811_bb0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1148\/radiol.12111472","article-title":"Pseudoprogression of glioblastoma after chemo-and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival","volume":"266","author":"Gahramanov","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2025.102811_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13244-015-0404-2","article-title":"The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review","volume":"6","author":"Kuijs","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1016\/j.nano.2025.102811_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200134","article-title":"Theranostics for MRI-guided therapy: recent developments","volume":"3","author":"Zhang","year":"2022","journal-title":"View"},{"key":"10.1016\/j.nano.2025.102811_bb0145","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1039\/C7TC05854C","article-title":"Magnetic iron oxide nanoparticles as T 1 contrast agents for magnetic resonance imaging","volume":"6","author":"Bao","year":"2018","journal-title":"Journal of Materials Chemistry C"},{"key":"10.1016\/j.nano.2025.102811_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1740","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging","volume":"14","author":"Chen","year":"2022","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102811_bb0155","doi-asserted-by":"crossref","first-page":"1906539","DOI":"10.1002\/adma.201906539","article-title":"Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives","volume":"33","author":"Jeon","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2025.102811_bb0160","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/adfm.201103123","article-title":"Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents","volume":"22","author":"Li","year":"2012","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.nano.2025.102811_bb0165","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja203340u","article-title":"Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T 1 magnetic resonance imaging contrast agents","volume":"133","author":"Kim","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2025.102811_bb0170","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1620145114","article-title":"Exceedingly small iron oxide nanoparticles as positive MRI contrast agents","volume":"114","author":"Wei","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2025.102811_bb0175","doi-asserted-by":"crossref","DOI":"10.1039\/D4NA00692E","article-title":"Amphoteric \u03b2-cyclodextrin coated iron oxide magnetic nanoparticles: new insights into synthesis and application in MRI","author":"Calsolaro","year":"2025","journal-title":"Nanoscale Advances"},{"key":"10.1016\/j.nano.2025.102811_bb0180","doi-asserted-by":"crossref","first-page":"1804567","DOI":"10.1002\/adma.201804567","article-title":"Structure\u2013relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2025.102811_bb0185","series-title":"Uchil, Analysis of Cell Viability by the alamarBlue Assay, Cold Spring Harbor Protocols, 2018","author":"Kumar","year":"2018"},{"key":"10.1016\/j.nano.2025.102811_bb0190","article-title":"Histological characterization of the human scapholunate ligament","author":"Alaminos","year":"2023","journal-title":"Authorea Preprints"},{"key":"10.1016\/j.nano.2025.102811_bb0195","article-title":"Endovascular addressing improves the effectiveness of magnetic targeting of drug carrier. Comparison with the conventional administration method","volume":"28","author":"Mayorova","year":"2020","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.nano.2025.102811_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmmm.2024.172447","article-title":"Citrate stabilized maghemite hydrosol with controllable MRI contrast: key role of nanoparticle size","volume":"608","author":"Moiseeva","year":"2024","journal-title":"Journal of Magnetism and Magnetic Materials"},{"key":"10.1016\/j.nano.2025.102811_bb0205","series-title":"Photometric Methods in Inorganic Trace Analysis","author":"Upor","year":"1985"},{"key":"10.1016\/j.nano.2025.102811_bb0210","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.chemosphere.2007.02.015","article-title":"The effect of pH on the kinetics of spontaneous Fe (II) oxidation by O2 in aqueous solution\u2013basic principles and a simple heuristic description","volume":"68","author":"Morgan","year":"2007","journal-title":"Chemosphere"},{"key":"10.1016\/j.nano.2025.102811_bb0215","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1021\/acsanm.1c00987","article-title":"Nanoparticle size effects in biomedical applications","volume":"4","author":"Dolai","year":"2021","journal-title":"ACS Applied Nano Materials"},{"key":"10.1016\/j.nano.2025.102811_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.bioconjchem.6b00575","article-title":"Size-dependent protein\u2013nanoparticle interactions in citrate-stabilized gold nanoparticles: the emergence of the protein corona","volume":"28","author":"Piella","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2025.102811_bb0225","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/ar300031y","article-title":"Physicochemical properties determine nanomaterial cellular uptake, transport, and fate","volume":"46","author":"Zhu","year":"2013","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2025.102811_bb0230","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1103\/PhysRev.73.679","article-title":"Relaxation effects in nuclear magnetic resonance absorption","volume":"73","author":"Bloembergen","year":"1948","journal-title":"Phys Rev"},{"key":"10.1016\/j.nano.2025.102811_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1103\/PhysRev.99.559","article-title":"Relaxation processes in a system of two spins","volume":"99","author":"Solomon","year":"1955","journal-title":"Phys Rev"},{"key":"10.1016\/j.nano.2025.102811_bb0240","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1063\/1.1731684","article-title":"Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation","volume":"34","author":"Bloembergen","year":"1961","journal-title":"The Journal of Chemical Physics"},{"key":"10.1016\/j.nano.2025.102811_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200059","article-title":"Supramolecular design based activatable magnetic resonance imaging","volume":"2","author":"Geng","year":"2021","journal-title":"View"},{"key":"10.1016\/j.nano.2025.102811_bb0250","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/la063415s","article-title":"Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T 1 magnetic resonance imaging contrast agents for molecular imaging","volume":"23","author":"Taboada","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2025.102811_bb0255","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1039\/c2cp23196d","article-title":"Ultrasmall water-soluble metal-iron oxide nanoparticles as T 1-weighted contrast agents for magnetic resonance imaging","volume":"14","author":"Zeng","year":"2012","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.nano.2025.102811_bb0260","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.1039\/C7NR04181K","article-title":"T 1-enhanced MRI-visible nanoclusters for imaging-guided drug delivery","volume":"9","author":"Sherwood","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2025.102811_bb0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41551-022-00975-2","article-title":"A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging","volume":"7","author":"Zhang","year":"2023","journal-title":"Nature biomedical engineering"},{"key":"10.1016\/j.nano.2025.102811_bb0270","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1002\/adma.201304744","article-title":"Anchoring group effects of surface ligands on magnetic properties of Fe3O4 nanoparticles: towards high performance MRI contrast agents","volume":"26","author":"Zeng","year":"2014","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2025.102811_bb0275","series-title":"Why gadolinium matters today","author":"Enterline","year":"2023"},{"key":"10.1016\/j.nano.2025.102811_bb0280","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/biom12060742","article-title":"Gadolinium in medical imaging\u2014usefulness, toxic reactions and possible countermeasures\u2014a review","volume":"12","author":"Blomqvist","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.nano.2025.102811_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/ird3.87","article-title":"Precise diagnosis of cardiac-cerebral vascular diseases with magnetic resonance imaging-based nanoprobes","author":"Li","year":"2024","journal-title":"iRADIOLOGY"},{"key":"10.1016\/j.nano.2025.102811_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.740716","article-title":"Iron is filtered by the kidney and is reabsorbed by the proximal tubule","volume":"12","author":"Wareing","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.nano.2025.102811_bb0295","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/toxsci\/kfj027","article-title":"Toxicity and tissue distribution of magnetic nanoparticles in mice","volume":"89","author":"Kim","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.nano.2025.102811_bb0300","series-title":"Guidance for Industry: Developing Medical Imaging Drug and Biological Products","author":"Food","year":"2004"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:19:51Z","timestamp":1778818791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"alternative-id":["S1549963425000115"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102811","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasmall maghemite nanoparticles as MRI contrast agent: Unique combination of aggregation stability, low toxicity, and tumor visualization","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102811"}}